Figure 1.
Trial profiles
Per-protocol set used for immunogenicity analyses at day 28, and those additionally analysed at day 56 after two doses. OPV2=type 2 oral poliovirus vaccine.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.